Reference
Xencor Inc. Xencor Announces Partial Clinical Hold on Phase 1 Study of XmAb14045. Internet Document : 20 Feb 2019. Available from: URL: https://www.prnewswire.com/news-releases/xencor-announces-partial-clinical-hold-on-phase-1-study-of-xmab14045-300798467.html
Rights and permissions
About this article
Cite this article
Xencor's blood cancer antibody on partial clinical hold in US. Reactions Weekly 1743, 5 (2019). https://doi.org/10.1007/s40278-019-58693-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-58693-1